Envestnet Asset Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.7M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.05M | Buy |
|
|||||
|
2023
Q1 | $1.53M | Buy |
|
|||||
|
2022
Q4 | $1.23M | Buy |
|
|||||
|
2022
Q3 | $1.19M | Sell |
|
|||||
|
2022
Q2 | $5.56M | Buy |
|
|||||
|
2022
Q1 | $1.94M | Buy |
|
|||||
|
2021
Q4 | $1.95M | Buy |
|
|||||
|
2021
Q3 | $1.9M | Sell |
|
|||||
|
2021
Q2 | $2.11M | Sell |
|
|||||
|
2021
Q1 | $2.16M | Buy |
|
|||||
|
2020
Q4 | $2.2M | Sell |
|
|||||
|
2020
Q3 | $1.86M | Sell |
|
|||||
|
2020
Q2 | $1.9M | Buy |
|
|||||
|
2020
Q1 | $1.34M | Buy |
|
|||||
|
2019
Q4 | $1.38M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $1.49M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.74M | Buy |
|
|||||
|
2018
Q2 | $40K | Buy |
|
|||||
|
2018
Q1 | $35K | Buy |
|
|||||
|
2017
Q4 | $38K | Sell |
|
|||||
|
2017
Q3 | $45K | Hold |
|
|||||
|
2017
Q2 | $46K | Buy |
|
|||||
|
2017
Q1 | $36K | Hold |
|
|||||
|
2016
Q4 | $34K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $63K | Sell |
|
|||||
|
2016
Q1 | $62K | Sell |
|
|||||
|
2015
Q4 | $90K | Sell |
|
|||||
|
2015
Q3 | $340K | Sell |
|
|||||
|
2015
Q2 | $6.55M | Sell |
|
|||||
|
2015
Q1 | $7.13M | Buy |
|
|||||
|
2014
Q4 | $3.88M | Buy |
|
|||||
|
2014
Q3 | $3.47M | Sell |
|
|||||
|
2014
Q2 | $3.44M | Buy |
|
|||||
|
2014
Q1 | $1.19M | Sell |
|
|||||
|
2013
Q4 | $2.14M | Buy |
|
|||||
|
2013
Q3 | $261K | Buy |
|
|||||
|
2013
Q2 | $68K | Buy |
|